SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as community members rally behind the stock, fueled by potential catalysts like a new CEO announcement and optimism around future interest rate cuts. The stock's recent surge has sparked discussions of a potential short squeeze and gamma squeeze, with retail investors expressing strong bullish sentiment. A well-known celebrity recently announced their support of $OPEN adding fuel to the fire.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a land sale agreement potentially boosting its NAV, attracting attention for its small float and potential for a significant upward move. Community discussions highlight the possibility of a short squeeze, comparing it to other recent low float runners. The stock's low float and increasing volume are key talking points.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community anticipates upcoming earnings, speculating on profitability and potential impacts from new ventures like trading cards and the collectibles market. Some traders are weighing the possibility of a Roaring Kitty return, while others debate the stock's long-term prospects and the potential for market manipulation. There's also discussion of a possible Lego partnership and its impact on revenue.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid speculation of a potential acquisition following leadership changes, with Nestle being a frequently mentioned suitor. Community discussions focus on the possibility of a merger or strategic partnership to bolster the company's finances and pipeline. The stock's high short interest and low float are also fueling hopes for a potential short squeeze.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending amid discussions about its AI capabilities and potential, with community members debating whether the market is properly valuing its AI narrative. Some are pointing to significant buybacks and undervaluing while others are cautious, citing volatility and the company's AI transition. Overall, conversation is centered on Baidu's potential for growth in the AI sector.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries ($FORD) is trending due to a significant after-hours surge, driven by speculative momentum and social media buzz, despite no clear news catalyst. The community is actively discussing whether this surge is sustainable, with some mistaking it for Ford Motor Company ($F), while others point to its low float and potential for a short squeeze. Overall, Forward Industries is attracting attention as a low-float stock with potential for volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is trending amid discussions about its connections to political figures, the launch of a Trump-backed stablecoin, and general market volatility. The community is expressing concerns about potential financial risks and ethical considerations, with some questioning the company's fundamentals. Commentary ranges from political accusations to speculation about the stock's future performance.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending due to anticipation surrounding its upcoming earnings announcement, which will be unusually presented from the floor of the NYSE, fueling speculation of major news. The community is actively discussing potential partnerships, buyouts, and a positive forward outlook. Investors are also eyeing the company's strong revenue growth and AI capabilities within the burgeoning space economy.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending following the launch of its new AI model, Qwen-3-Max, and reports of a new AI chip, fueling optimism about the company's AI capabilities and cloud growth potential. Community discussions revolve around price targets, potential for a short squeeze, and comparisons to other tech giants like Nvidia. Broader market context includes renewed investor confidence in Chinese tech stocks and speculation about future growth in the AI sector.

Brewski

BREWSKI.X is trending as the community discusses potential whale activity and its potential as the "next runner." Amidst this, some users are also pointing to concerns of a potential rug pull due to the homepage being taken down. The token is also being associated with a patriotic, "America is back" narrative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default

Syros Pharmaceuticals' Phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome did not meet primary endpoints, impacting future trial plans.
read more...

Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that the...

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update

Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial...

Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syros Pharmaceuticals, Inc. (Syros or the Company) (NASDAQ: SYRS). Investors who...

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Syros Pharmaceuticals, Inc. (SYRS) Investigation...

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Current Price	$0.0011
Prev Close	$0.0017
Open	$0.0017
Dividend Yield	N/A
50-Day Moving Average	$0.0087
Beta	1.89
Avg. Volume	19,201.19
PE Ratio	0.00

52-Week High	$3.40
52-Week Low	$0.0002
Market Capitalization	$29,500.00
EPS (Annual)	N/A
Price to Book	-0.00
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

SYRS
Syros Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SYRS News

SYRS Syros Pharmaceuticals Inc.